Villalón, C M <br/><br/>
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.  [electronic resource] 

 -  British journal of pharmacology  Feb 1999 
 - 585-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1188 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjp.0702324  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-1 Receptor Antagonists<br/>Adrenergic alpha-2 Receptor Agonists<br/>Adrenergic alpha-2 Receptor Antagonists<br/>Adrenergic alpha-Agonists--pharmacology<br/>Adrenergic alpha-Antagonists--pharmacology<br/>Animals<br/>Blood Flow Velocity--drug effects<br/>Carotid Arteries--drug effects<br/>Clonidine--pharmacology<br/>Dihydroergotamine--pharmacology<br/>Dogs<br/>Ergotamine--pharmacology<br/>Female<br/>Hemodynamics--drug effects<br/>Male<br/>Methysergide--pharmacology<br/>Oxadiazoles--pharmacology<br/>Phenylephrine--pharmacology<br/>Piperazines--pharmacology<br/>Prazosin--pharmacology<br/>Receptor, Serotonin, 5-HT1B<br/>Receptor, Serotonin, 5-HT1D<br/>Receptors, Adrenergic, alpha-2--physiology<br/>Receptors, Serotonin--drug effects<br/>Serotonin Antagonists--pharmacology<br/>Sumatriptan--pharmacology<br/>Vasoconstriction--drug effects<br/>Vasoconstrictor Agents--pharmacology<br/>Yohimbine--pharmacology